Tea Reljic

1.8k total citations
91 papers, 1.1k citations indexed

About

Tea Reljic is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Tea Reljic has authored 91 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 20 papers in Public Health, Environmental and Occupational Health and 15 papers in Genetics. Recurrent topics in Tea Reljic's work include Acute Myeloid Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (10 papers) and Hematopoietic Stem Cell Transplantation (10 papers). Tea Reljic is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (10 papers) and Hematopoietic Stem Cell Transplantation (10 papers). Tea Reljic collaborates with scholars based in United States, Lebanon and India. Tea Reljic's co-authors include Ambuj Kumar, Benjamin Djulbegović, Mohamed A. Kharfan‐Dabaja, Mehdi Hamadani, Ernesto Ayala, Taiga Nishihori, Rahul Mhaskar, Ali Bazarbachi, Mohamad Mohty and Jeffrey E. Lancet and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Tea Reljic

84 papers receiving 1.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Tea Reljic 374 243 182 175 161 91 1.1k
Elizabeth Tanjong Ghogomu 563 1.5× 91 0.4× 171 0.9× 476 2.7× 154 1.0× 38 2.0k
Markus M. J. Nielen 202 0.5× 137 0.6× 149 0.8× 339 1.9× 162 1.0× 26 2.0k
Shahin Jamal 219 0.6× 221 0.9× 47 0.3× 229 1.3× 101 0.6× 52 1.1k
Helga Radner 543 1.5× 106 0.4× 69 0.4× 416 2.4× 292 1.8× 69 2.4k
Thomas Mittendorf 160 0.4× 161 0.7× 146 0.8× 253 1.4× 308 1.9× 105 1.7k
Yan Ma 97 0.3× 219 0.9× 66 0.4× 164 0.9× 288 1.8× 119 1.6k
Bente Glintborg 629 1.7× 87 0.4× 106 0.6× 1.0k 5.7× 114 0.7× 109 2.3k
Mitsumasa Kishimoto 803 2.1× 154 0.6× 112 0.6× 1.1k 6.2× 186 1.2× 162 2.9k
Anne Marie Whelan 117 0.3× 88 0.4× 422 2.3× 277 1.6× 137 0.9× 88 1.7k
Diederik De Cock 309 0.8× 58 0.2× 151 0.8× 141 0.8× 51 0.3× 93 1.0k

Countries citing papers authored by Tea Reljic

Since Specialization
Citations

This map shows the geographic impact of Tea Reljic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tea Reljic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tea Reljic more than expected).

Fields of papers citing papers by Tea Reljic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tea Reljic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tea Reljic. The network helps show where Tea Reljic may publish in the future.

Co-authorship network of co-authors of Tea Reljic

This figure shows the co-authorship network connecting the top 25 collaborators of Tea Reljic. A scholar is included among the top collaborators of Tea Reljic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tea Reljic. Tea Reljic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reljic, Tea, Ambuj Kumar, Sharon Cox, et al.. (2025). Evidence‐Based Surgical Guidelines for Treating Children With Rhabdomyosarcoma. Pediatric Blood & Cancer. 72(4). e31541–e31541. 1 indexed citations
2.
Kharfan‐Dabaja, Mohamed A., Tea Reljic, Razan Mohty, et al.. (2025). Treatment of Diffuse Large B-cell Lymphoma Progressing or Relapsing after Chimeric Antigen Receptor T-cell Therapy. Transplantation and Cellular Therapy. 31(11). 898.e1–898.e12.
3.
Mohty, Razan, Tea Reljic, Talha Badar, et al.. (2024). Efficacy of Autologous and Allogeneic Hematopoietic Cell Transplantation in Adults with Acute Promyelocytic Leukemia: Results of a Systematic Review and Meta-Analysis. Transplantation and Cellular Therapy. 30(6). 599.e1–599.e10. 1 indexed citations
4.
Mohty, Razan, Tea Reljic, Omer Jamy, et al.. (2024). Assessing the efficacy of allogeneic hematopoietic cell transplantation in VEXAS syndrome: results of a systematic review and meta-analysis. Bone Marrow Transplantation. 59(10). 1423–1427. 5 indexed citations
5.
Błoński, Wojciech, et al.. (2024). A systematic critical appraisal of clinical practice guidelines of antithrombotic agents in gastrointestinal endoscopy using the AGREE II tool. Journal of Gastroenterology and Hepatology. 39(5). 818–825. 3 indexed citations
6.
Reljic, Tea, T.P. Smith, Fadila Serdarević, et al.. (2024). PPAR agonists as add-on treatment with metformin in management of type 2 diabetes: a systematic review and meta-analysis. Scientific Reports. 14(1). 8809–8809. 14 indexed citations
8.
Reljic, Tea, et al.. (2024). A Systematic Critical Appraisal of Clinical Practice Guidelines in Barrett’s Esophagus Using the AGREE II Tool. Journal of Clinical Gastroenterology. 60(1). 33–39. 1 indexed citations
9.
Miles, Shannon R., Sarah L. Martindale, Julianne C. Flanagan, et al.. (2023). Putting the pieces together to understand anger in combat veterans and service members: Psychological and physical contributors. Journal of Psychiatric Research. 159. 57–65.
11.
Suz, Pilar, Tea Reljic, Ambuj Kumar, et al.. (2022). Perioperative Carcinoid Crisis: A Systematic Review and Meta-Analysis. Cancers. 14(12). 2966–2966. 13 indexed citations
12.
Epperla, Narendranath, Tea Reljic, Sayan Mullick Chowdhury, et al.. (2022). Autologous hematopoietic cell transplantation versus whole‐brain radiotherapy consolidation in primary central nervous system lymphoma: A systematic review and meta‐analysis. Hematological Oncology. 41(1). 88–96. 7 indexed citations
13.
Reljic, Tea, Sean Phillips, Christine Burke, et al.. (2020). Impact of Comorbid PTSD on Outcome of Repetitive Transcranial Magnetic Stimulation (TMS) for Veterans With Depression. The Journal of Clinical Psychiatry. 81(4). 15 indexed citations
14.
Silva, Marc A., Tea Reljic, Kristen Dams-O’Connor, et al.. (2020). Rehabilitation Needs at 5 Years Post-Traumatic Brain Injury: A VA TBI Model Systems Study. Journal of Head Trauma Rehabilitation. 36(3). 175–185. 19 indexed citations
16.
Djulbegović, Benjamin, Paul Glasziou, Tea Reljic, et al.. (2018). Larger effect sizes in nonrandomized studies are associated with higher rates of EMA licensing approval. Journal of Clinical Epidemiology. 98. 24–32. 25 indexed citations
17.
Li, Shelly‐Anne, Paul Alexander, Tea Reljic, et al.. (2018). Evidence to Decision framework provides a structured “roadmap” for making GRADE guidelines recommendations. Journal of Clinical Epidemiology. 104. 103–112. 30 indexed citations
18.
Reljic, Tea, et al.. (2017). Treatment targeted at underlying disease versus palliative care in terminally ill patients: a systematic review. BMJ Open. 7(1). e014661–e014661. 24 indexed citations
19.
Charan, Jaykaran, Mayur Chaudhari, Ryan S. Jackson, et al.. (2015). Comparison of methodological quality of positive versus negative comparative studies published in Indian medical journals: a systematic review. BMJ Open. 5(6). e007853–e007853. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026